Can Liquid Biopsy Transform Chronic Disease? Hamed Amini and Soheil Damangir of Hepta
About this episode
The episode discusses the potential of liquid biopsy in transforming the understanding and treatment of chronic diseases.
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com For the past decade, liquid biopsy has largely been defined by oncology. Tumors shed DNA carrying mutations and epigenetic changes which allows researchers to detect cancer and monitor response. With this physicians are increasingly able to guide treatment. But chronic diseases are different. There is no tumor. Biological signals are subtle and quite d…
People in this episode
Host: Theral Timpson
Guests: Hamed Amini, Soheil Damangir
Topics covered
- liquid biopsy
- chronic disease
- oncology
- DNA mutations
- treatment monitoring
Mentioned in this episode
Organizations: Hepta
More episodes of Mendelspod Podcast
- Agilent and Oxford Nanopore Discuss Bringing Long Reads to the Clinic with a Customer
- Liquid Biopsy for the Tumor Microenvironment: with Vince Miller and Mirna Jarosz
- The UAE’s Big Bet on Genomic Medicine with Mohamed Alameri and Albarah El-Khani
- Ryan Flynn of Harvard on Non-Coding RNA
Explore listener stats, chart rankings, contacts and more on the Mendelspod Podcast podcast page.